As the situation with COVID-19 evolves, the PharPoint Research team is taking necessary precautions to ensure study operations continue uninterrupted.

During this critical time in our industry, PharPoint remains fully dedicated, as always, to helping clients improve global health.

Our leadership team has been closely monitoring the situation since the initial outbreak and have proper risk mitigation strategies in place. These include, work from home protocols for our fully-trained staff, contingency plans in the event of any physical office or site closures, and a review of our communication practices to ensure continuous support.

PharPoint Research has long maintained robust work remote capabilities and processes. In the event of office closures, there will be minimal disruptions to ensure continuous business operations.

PharPoint Research will continue to support clients to our same high standards throughout this time.

Both the continued support of our client’s invaluable work in improving the lives of patients and the safety of our employees are top priorities.

Together, we can overcome these challenging times.

Exploring Standard CRO Timeline Benchmarks

Preparing to work with a top biometrics contract research organization and wondering how their promised data management, biostatistics, and medical writing timelines match up to the industry average? To help sponsors dig into these details and ensure the timelines they’re receiving are competitive, we’re providing PharPoint’s typical timelines alongside research that calculates industry standard timelines, when available.

Our hope is that this document can help sponsors set realistic expectations, confidently ask the right questions of their vendors, and ultimately, partner with a top biometrics CRO that keeps their study moving: because patients are waiting.

eBook contents include:

PharPoint’s short eBook, Standard Clinical Trial Timelines: A Sponsor’s Guide to Evaluating Biometrics CROs, includes the below information.

• Standard database build timeline
  • The bigger picture: Considering site identification and study start-up
• Standard mid-study database change timeline
• Standard database lock time
  • Six strategies for a faster database lock
• Evaluating database lock to top line results timeline
  • Ensuring a rapid delivery
• Evaluating database lock to delivery of tables, listings, and figures (TLF) timeline
• Standard clinical study report delivery timeline
• About PharPoint Research